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Management of tracheobronchial obstruction in infants using metallic stents: Long-
term outcome  
 
Abstract 
Introduction: 
Tracheobronchial obstruction, although uncommon in the paediatric age group, remains a 
challenging problem. We review the long term outcome of endoscopic metallic stenting 
in infants with tracheobronchial obstruction. 
Materials and methods: 
Medical records of all paediatric surgical patients who underwent tracheobronchial 
metallic stenting in our centre were reviewed retrospectively from 1996 to 2014. Patients’ 
demographic data, including etiology, associated anomalies and nature of obstruction 
were reviewed. Outcome measures include complications such as re-stenosis, granulation 
tissue, stent migration, fractured stent, maximal tracheal diameter achieved, weaning of 
ventilator and growth at interval follow-up.  
Results:  
Twelve balloon-expandable metallic stents were placed in the trachea (n=10) and/or 
bronchi (n=2) of 5 patients with a median age of 13 months (range 5 - 30 months). 
Etiology of the airway obstruction included congenital tracheal stenosis (n=4), giant 
cervical and superior mediastinal lymphatic malformation with tracheobronchomalacia 
(n=1). Seven complications were reported (3 patients developed granulation tissue, 2 
patients had re-stenosis, 1 stent migrated, 1 stent fractured). All patients survived and 
were in good condition with a median follow-up of 16 years (range 11 – 18 years). Three 
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patients weaned off ventilator and oxygen. 
Conclusions: 
Endoscopic stenting with metallic stent has satisfactory long term outcome in treating 
infants with tracheobronchial obstruction. 
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Article 
Introduction 
Airway obstruction in paediatric patients remains a challenging problem among clinicians. 
Obstruction can be due to various extraluminal, intramural and intraluminal diseases. 
Congenital tracheomalacia and stenosis are the most common causes. A number of 
surgical treatment options have been advocated. Tracheoplasty can be done either by 
tracheal resection and anastomosis or by repair using costal cartilage or pericardial patch. 
[1,2] However, these operations may be difficult for small children with respiratory 
failure and have a high risk of operative mortality. Aortopexy has been shown to be 
effective in cases of short-segment tracheomalacia. [3-5] Endoscopic stenting has been 
shown to reduce the need for high risk surgical procedure and prolonged ventilator 
dependence in children with diffuse tracheomalacia. In difficult population, endoscopic 
stenting has been recommended as an alternative therapeutic option. [6-17] Currently, 
there is only scanty information regarding the long term outcome of this procedure. The 
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purpose of this study is to review our experience in treating congenital tracheobronchial 
obstruction with endoscopic stent placement. 
 
Materials and methods 
Medical records of all paediatric surgical patients who underwent tracheobronchial 
stenting in our centre were reviewed retrospectively from 1996 to 2014. Patients’ 
demographic data, including etiology, associated anomalies and nature of obstruction 
were reviewed. Outcome measures include complications such as re-stenosis, granulation 
tissue, stent migration, fractured stent, maximal tracheal diameter achieved, weaning of 
ventilator and growth at interval follow-up.  
Endoscopic stenting was offered to patients who had significant recurrent stenosis 
following repeated dilatations. As the number of patients with this condition was very 
small, our ENT colleagues did not have the expertise in performing tracheoplasties. As a 
result, we were only able to offer endoscopic stenting to patients. In addition it had the 
advantage of being minimally invasive. Selection of the stent type depended on the 
location of obstruction, the patient's age and body size as well as the availability of the 
stent at the time of procedure. Prior to stent placement, the type, location, severity, and 
length of the obstruction were assessed by bronchoscopy and computer tomography. In 
all of our patients, metallic balloon-expandable Palmaz stents (Johnson & Johnson 
Interventional Systems, Warren, NJ) were placed using a Storz rigid paediatric 
bronchoscope (Karl Storz, Germany) under general anaesthesia. The site for stenting was 
determined by simultaneous use of endoscopy and fluoroscopy. The stent, together with a 
angioplasty balloon catheter, were passed through the bronchoscope. Under fluoroscopic 
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control, the balloon was inflated by normal saline and the position of expanded stent was 
confirmed. (Figures 1&2). The tracheal mucosa was visualized by rigid bronchoscopy. 
The balloon was deflated and the catheter was removed. 
 
Results 
Five patients presented with respiratory distress in the neonatal or early infantile period. 
Patient demographics, the anatomy of tracheobronchial obstruction, number and location 
of the stents and complications were summarized in Table 1. Etiology of the airway 
obstruction included congenital tracheal stenosis (n=4), giant cervical and superior 
mediastinal lymphatic malformation with tracheobronchomalacia (n=1). One patient 
(patient 4) had concomitant multiple congenital anomalies including cerebral atrophy and 
severe hydrocephalus. The diameter of the obstructed segments ranged from 1 mm to 2 
mm and the length from 14mm to the entire trachea.  
The median age at first stenting was 13 months (range 5 - 30 months). Four patients had 
undergone rigid bronchoscopies and balloon dilatations to expand the airway before stent 
placements, ranging from 7 to 19 sessions. One patient (patient 5) with extensive 
tracheobronchial compression due to giant cervical and superior mediastinal lymphatic 
malformation was initially managed by open excision of the lesion, which subsequently 
recurred. A total of twelve Palmaz stents were placed in the trachea (n=10) and/or bronchi 
(n=2) in 5 patients. Four patients required placements of more than one stent, these were 
placed during repeated bronchoscopic procedures. All stents, except one fractured stent in 
patient 5, remained in place. There was no peri-operative mortality.  
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Long term outcome 
A summary of long term outcome was presented in table 2. All patients needed regular 
bronchoscopic assessments and balloon dilatations to maintain luminal patency. A median 
of 25 bronchoscopies (range 21 – 55) and 14 balloon dilatations (range 9 – 40) had been 
performed. Gradual increase in tracheal diameter was noted. The median maximal 
tracheal diameter achieved was 13 mm (range 8 – 17 mm).  
All patients survived and were in good condition with a median follow-up of 16 years 
(range 11 – 18 years) from their initial presentation. Three patients weaned off ventilator 
and oxygen. Two patients require home oxygen support in the form of positive airway 
pressure. All except one patient with profound mental retardation had satisfactory 
exercise tolerance for normal daily activity. Three patients had normal body weight and 
height, whereas two patients remained below the 3rd percentile.  
 
Patient 1 
No complications occurred throughout the eighteen years post-stenting. He remained 
ventilator free and enjoyed normal exercise capacity and growth.  
 
Patient 2 
In patient 2, two stents were inserted to distal trachea. Stent migration into the left lower 
lobe bronchus was noted six years post-stenting, which was managed conservatively. She 
was ventilator free and had an exercise tolerance of three flights of stairs.  
 
Patient 3 
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In patient 3, re-stenosis proximal to the stent occurred 2 months after placement of stent 
and intensive care was required. It was managed by bronchoscopic dilatations and 
dexamethasone injection. On subsequent bronchoscopic reassessments, airway patency 
was maintained except granulation tissue was seen requiring removal by endoscopic 
cauterization twice. He had mild mental retardation, otherwise he enjoyed normal 
exercise capacity. 
 
Patient 4 
He had multiple congenital anomalies with profound mental retardation, hydrocephalus 
and obstructive sleep apnea. He developed a total of 12 episodes of pneumonia after 
bronchoscopies. This could result from his co-existing gastroesophageal reflux disease 
and he eventually underwent laparoscopic fundoplication and gastrostomy. Reassessment 
bronchoscopy at 4 months post-stenting showed granulation tissue at sub-glottic area and 
was removed. He was wheelchair bound and required nocturnal continuous positive 
airway pressure ventilation at home. 
 
Patient 5 
In patient 5, Palmaz stent was inserted at one and a half year of age. Three months later, a 
second stent was inserted in view of a malacic segment of the trachea above the first stent. 
However, it was complicated by stent fracture and was managed by balloon dilatation and 
adrenaline injection. Reassessment bronchoscopy showed obstructing granulation tissue 
over both bronchi requiring bilateral bronchial stents insertion. During her 35th 
bronchoscopy, granulation tissue was found to cause a ball-valve effect, and there were 
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migration and fracture of the tracheal stent. Granulation tissue and the stent fragment 
were removed by suction and forceps until patency of the tracheal lumen was confirmed. 
Despite her difficult clinical condition and stormy hospitalizations, she had normal 
growth and intelligence. She required bilevel positive airway pressure ventilation at home, 
nonetheless, her normal daily activity was not affected. 
 
Discussion 
The first report regarding the use of tracheobronchial stents in children dated back to the 
late 1980s. [6,7,18] Endoscopic stents had been used in various clinical conditions 
including airway malacia or stenoses, either due to external compression or structurally 
abnormal airway walls. Its use in post-operative stenosis after lung transplantation had 
also been reported. [13] Such procedures were usually performed in combination with 
surgery for the treatment of severe bronchomalacia or for the prevention of post-
tracheoplasty re-stenosis. 
In 1995, Zinman [19] showed that tracheal stenting improved ventilatory mechanics in 
infants with tracheobronchomalacia. The use of vascular mesh metal prosthesis (Palmaz) 
in 16 children was first introduced by Filler et al. [9] The stents were reported to be well 
tolerated for up to 6 years.  
Different classes of stents have been developed for airway stenosis. They can be broadly 
classified into plastic and metallic. For plastic stents, standard silicone stent is easily 
removable while Dumon stent is flexible. [20] Silicone stent has major limitations of 
being easily collapsible, prone to migration and interruption of mucociliary clearance. Its 
use in infants is not well tolerated because of frequent obstruction by secretions. The use 
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of Polyflex stent, a self expanding silicone device, had been reported. However, 
migration and mucus impaction occurred in all 12 patients with stenoses. [21]  
Concerning metallic stents, the main division is balloon-expandable and self expanding 
types. These were originally intended for angiographic applications in adults. Palmaz 
stent is made of stainless steel and is balloon expandable. The risks of obstruction by 
mucus and migration were less than that of silicone stents. Palmaz stents had been shown 
in an experimental trial to provoke an inflammatory reaction and epithelialization. [22] 
When compared to self expanding stents, Palmaz stent had the advantage of expansion 
under direct observation. Balloon dilatation was performed first to a satisfactory size, 
followed by insertion of the Palmaz stent to maintain luminal patency. A major 
disadvantage of Palmaz stent was difficult and risky adjustment or removal.  
Wallstent, on the other hand, is made of thin wire which allows flexibility. As a result, it 
is most frequently seen in relief of vascular compression by self-expanding properties. 
Balloon expanding is contraindicating as it may lead to vascular erosion. [11,21,23] 
However, self expanding stents might subject the tracheal wall to expanding forces, 
leading to significant airway damage.  
Nitinol stent composed of a nickel-titanium alloy with ‘‘shape memory effect’’ had been 
studied in a few case series. In the recent series by Siegel et al, [24] six out of seven 
patients underwent stenting as a salvage procedure following open attempts at airway 
reconstruction. Four patients remained decannulated with their stent in place. 
Complications included stent migration (23%), re-stenosis (29%), edema (29%), and 
granulation (57%). The authors concluded nitinol stents were reserved only as a salvage 
procedure in severely complicated airways.  
9 
 
Recently, new stents that are more biocompatible were being investigated. [25,26] 
Biodegradable materials had been used experimentally for stenting of tracheobronchial 
stenosis since 1998. Polydioxanone is a biodegradable polymer that exhibits some shape 
memory and dissolves by 15 weeks. In a study by Vondrys et al, eleven stenting 
procedures were performed in 4 patients. Three patients needed repeated stenting after 
stent absorption. One patient died after withdrawal of care, the 3 survivors were in good 
ventilatory condition. [27] There was also a study on the use of Rapamycin-coated stents 
to prevent granulation formation [28]. More clinical application of these new stents is 
needed to justify the use. 
Complications had been reported after Palmaz stents were inserted. Filler et al [9] 
reported granulation tissue in six out of seven children stented for malacia. Two patients 
required repeated endoscopic excisions and dilatations, two patients underwent placement 
of additional stents. The granulation tissue was non-obstructing in two patients and they 
were managed conservatively. Furman et al [11] reported major complication of 
epithelialization arising from the use of metallic stents, which complicates stent removal. 
Other complications including complete erosion of the tracheobronchial wall have been 
reported [29,30]. Antón-Pacheco et al [31] reported three out of twelve patients with 
tracheal Palmaz stents showed prominent granulation tissue with clinical significance. In 
addition, stent migration and stent fracture are not uncommon [12].  
Although our series was among the few that had zero mortality, stent related mortality 
was reported to be 12.9% by Nicolai [13]. Santoro et al [8] reported two out of three 
neonates who underwent Palmaz stenting for tracheobronchomalacia died of sepsis after 
the procedure. Recurrent granulation tissue was potentially fatal, Maeda et al [14] 
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reported 5 infants with tracheal stenosis, one died from recurrent granulation tissue 
obstructing the trachea and intractable pneumonia after 9 months of palliation. Geller et 
al [16] reported 3 mortalities from tracheal haemorrhage and 1 from pulmonary 
complications among 9 patients who underwent Palmaz stent insertion for severe 
tracheomalacia. In that particular series, seven out of nine patients had co-existing cardiac 
disease.  
Experience in using silicone stenting had been reported by various centers over the world.  
However, the long-term effect of balloon-expandable metallic stents in children is 
unknown. 
Throughout the past ten years, we have applied the technique on five patients whom we 
thought will benefit from stenting. In general, the indication for considering long term 
stenting in this series is those who have significant recurrent stenosis following repeated 
dilatations. Other indications include extrinsic compression not correctable by surgery or 
focal malacia. Compared to other studies we had an acceptable complication rate. [10-
12,32] The most common complication was granulation tissue formation, which occurred 
in three of our patients. Patient 5, the girl with a giant cervical and superior mediastinal 
lymphatic malformation with tracheobronchomalacia, was particularly challenging to 
manage. Having a total of five stents placed to maintain airway patency, she eventually 
developed granulation, stent migration and fracture, necessitating multiple bronchoscopic 
removals of granulation tissue and stent fragments. The reason why some patients 
remained granulation free with normal epithelialization while others developed recurrent 
granulation formation was yet to be determined. In patient 5, although the stent was 
fractured and migrated, removal would be extremely difficult due to granulation 
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formation. It had been reported by an experimental study by Fraga et al [22] that attempts 
to remove stent could be fatal, the stent was found to be incorporated into the fibrotic 
tracheal wall and could not be removed even after death. Okuyama et al [33] had reported 
one successful removal of stent requiring cardiopulmonary bypass and reconstruction 
using slide tracheoplasty. They concluded stent removal by rigid bronchoscope should be 
regarded as a dangerous and possibly a fatal procedure. 
Despite the relatively low complication rate, our patients required a median of 25 
bronchoscopies post stenting under general anesthesia. With concerns about the effects of 
general anaesthesia on the developing brain, we believe stenting should be reserved for 
complex situations. 
Our study was one of the few published series with no reported stent related mortalities. 
[7,13,15] In view of high risk nature of this procedure, all our bronchoscopies were 
performed by surgeons, paediatric anaesthetists, operating theatre nurses and 
radiographers that had previous experiences. Paediatric intensivists were consulted for 
provision of post-operative support. We believed a multidisciplinary team approach was 
the cornerstone of our satisfactory outcome. 
Our study also had the longest follow duration (18 years) published to date. All children 
survived and their normal activities were not affected, except one patient who had 
profound mental retardation and was wheelchair bound. 
Given the rarity of this condition, our experience in this procedure is still limited. 
However, the fact that all patients still survive with reasonably good quality of life has 
given us much encouragement.  Complications can be managed accordingly. The patients 
only need to undergo regular bronchoscopic assessments with occasional dilatations. We 
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believe, endoscopic stenting has proved itself being a treatment option to manage 
tracheobronchial obstruction, a potentially fatal condition in infants, with satisfactory 
long term outcome. 
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Figure legends 
 
Fig. 1 - Fluoroscopy film showing multiple stents placed in trachea and both bronchi, 
pointed by arrows.  
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Fig. 2 - Fluoroscopy film taken during a balloon dilatation session 
 
 
Table 1. Patient demographics, number and location of stent(s) and complications 
 
 
 
Patient  
 
Present  
Age 
(years) 
Age at 
first 
stenting 
(months)  
Primary disease Anatomy of the stenotic/malacic segment Number and 
location of stent(s) 
Complications 
 
1 18  5  Congenital tracheal 
stenosis                                                                                                                                                                
Entire lower half of trachea extending 
down to carina 
 
1 in distal trachea  Nil 
2 16  14  Congenital tracheal 
stenosis                                                                                                                                                                 
Right bronchus was branching directly 
from the trachea. Stenotic trachea below 
that branching down to the carina and both 
mainstem bronchi 
2 in distal trachea  Re-stenosis 
3 17  13  Congenital tracheal 
stenosis     
14mm segment of tracheal stenosis 20mm 
above the carina with complete cartilage 
rings 
2 in distal trachea  Re-stenosis 
Granulation tissue  
4 11  11  Congenital tracheal 
stenosis     
20mm segment of tracheal stenosis 20mm 
above the carina with complete cartilage 
rings 
2 in distal trachea  Granulation tissue 
5 14  30 
 
Giant cervical and 
superior mediastinal 
lymphatic malformation 
 
Tracheobronchomalacia 
Tracheobronchomalacia due to 
compression from lymphatic malformation  
1 in distal trachea  
2 in proximal trachea  
1 in right bronchus  
1 in left bronchus  
 
Granulation tissue  
Stent migration 
Stent fracture 
Table 2. Long term outcome 
 
Patient  
number 
Total number 
of 
bronchoscopies 
Number of 
subsequent 
dilatations 
Maximal 
tracheal 
diameter 
achieved (mm) 
Oxygen 
requirement 
Exercise 
tolerance 
Growth Follow up 
duration 
(years) 
1 21 
 
9 14 Nil Normal Normal 18 
2 29 16 8 Nil 3 flights of 
stairs 
Below 3rd 
percentile 
16 
3 21 14 13 Nil Normal Below 3rd 
percentile 
17 
4 25 11 12 Nocturnal 
continuous 
positive 
airway 
pressure 
ventilation 
 
Wheelchair 
bound due to 
profound 
mental 
retardation 
10th percentile 11 
5 55 40 17 Home bilevel 
positive 
airway 
pressure 
ventilation 
Normal Normal 14 
 
 
 
